Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid

被引:84
作者
Chen, Alex M.
Ellison, Martha E.
Peresypkin, Andrey
Wenslow, Robert M.
Variankaval, Narayan
Savarin, Cecile G.
Natishan, Theresa K.
Mathre, David J.
Dormer, Peter G.
Euler, Danielle H.
Ball, Richard G.
Ye, Zhixiong
Wang, Yaling
Santos, Ivan
机构
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] Merck & Co Inc, West Point, PA 19486 USA
关键词
D O I
10.1039/b612353h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We report the first case of a pharmaceutical cocrystal formed between an inorganic acid and an active pharmaceutical ingredient (API), which enabled us to develop a stable crystalline and bioavailable solid dosage form for pharmaceutical development where otherwise only unstable amorphous free form or salts could have been used.
引用
收藏
页码:419 / 421
页数:3
相关论文
共 16 条
[1]   Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[2]  
Bettinetti G, 2000, J PHARM SCI, V89, P478, DOI 10.1002/(SICI)1520-6017(200004)89:4<478::AID-JPS5>3.0.CO
[3]  
2-5
[4]   Saccharin as a salt former. Enhanced solubilities of saccharinates of active pharmaceutical ingredients [J].
Bhatt, PM ;
Ravindra, NV ;
Banerjee, R ;
Desiraju, GR .
CHEMICAL COMMUNICATIONS, 2005, (08) :1073-1075
[5]   HYDROGEN-BONDING AND THERMAL VIBRATIONS IN CRYSTALLINE PHOSPHATE SALTS OF HISTIDINE AND IMIDAZOLE [J].
BLESSING, RH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1986, 42 :613-621
[6]   Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids [J].
Childs, SL ;
Chyall, LJ ;
Dunlap, JT ;
Smolenskaya, VN ;
Stahly, BC ;
Stahly, GP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (41) :13335-13342
[7]   Crystal engineering of the composition of pharmaceutical phases. 3. Primary amide supramolecular heterosynthons and their role in the design of pharmaceutical co-crystals [J].
McMahon, JA ;
Bis, JA ;
Vishweshwar, P ;
Shattock, TR ;
McLaughlin, OL ;
Zaworotko, MJ .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 2005, 220 (04) :340-350
[8]  
Newman AW, 2002, DRUGS PHARM SCI, V117, P1
[9]   The formation of paracetamol (acetaminophen) adducts with hydrogen-bond acceptors [J].
Oswald, IDH ;
Allan, DR ;
McGregor, PA ;
Motherwell, WDS ;
Parsons, S ;
Pulham, CR .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (06) :1057-1066
[10]   Carboxamide-pyridine N-oxide heterosynthon for crystal engineering and pharmaceutical cocrystals [J].
Reddy, LS ;
Babu, NJ ;
Nangia, A .
CHEMICAL COMMUNICATIONS, 2006, (13) :1369-1371